MedPath

BReath Hold TecHniquEs for Radiotherapy of Esophageal Carcinoma

Not Applicable
Terminated
Conditions
Esophageal Cancer
Registration Number
NCT06317272
Lead Sponsor
University Medical Center Groningen
Brief Summary

The main objective of the first part of the study is to determine the most optimal method for DIBH (active breathing control vs voluntary coached) and its reproducibility. Based on these findings, one of these methods will be selected for part 2 of this study.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1
Inclusion Criteria
  • Histologically proven esophageal cancer of the mid or distal esophagus
  • Scheduled for external-beam photon radiotherapy with curative intention.
  • WHO 0-2.
  • Age >= 18 years
  • Written informed consent.
Exclusion Criteria
  • Serious respiratory distress
  • Contra-indication for fiducial marker placement
  • Noncompliance with any of the inclusion criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Reproducibility DIBHWeek 1, 2, 3, 4, 5 during radiotherapy

Diaphragm dome position within 1cm of the baseline CT Target coverage \>94% of the prescribed dose (at 98% of the ITV)

Feasibility DIBHWeek 1, 2, 3, 4, 5 during radiotherapy

Breath hold maintained for \>20 seconds

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UMC Groningen

🇳🇱

Groningen, Netherlands

UMC Groningen
🇳🇱Groningen, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.